Delivery Order SPE2DB25D3306-SPE2DB25FUCRT
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Depakote DR 125 mg sprinkle capsules (100 count) with a ceiling value of $3,165.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is scheduled for ultimate completion on September 5, 2025, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,092.44 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $1,921.72. The award was made on July 30, 2025, with a completion date of July 31, 2025, under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,506.66 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.44 to AmerisourceBergen Drug Corp for DEPAKOTE ER 500 mg tablets (100-count) on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract utilizes firm fixed pricing and represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules, with a ceiling value of $1,824.98 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,015.34 to AmerisourceBergen Drug Corp for the supply of Depakote ER 250 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on June 6, 2025, is scheduled for completion by June 9, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $441.32 to Amerisourcebergen Drug Corp for 125mg sprinkle capsules of the pharmaceutical Depakote. As the prime contractor, Amerisourcebergen Drug Corp will deliver 100 capsules to a location in Conshohocken, Pennsylvania under a one-day period of performance from July 17 through July 18, 2023. The parent company, Amerisourcebergen Corporation, will perform the contract through its Amerisourcebergen Division. No...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Depakote DR 125 mg sprinkle capsules. The Delivery Order, valued at $1,350.72, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $437.37 to Amerisourcebergen Drug Corp for the supply of 100 units of 125mg Depakote Sprinkle capsules. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 5, 2023 under the terms of the contract starting September 1, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCRTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count units) with a ceiling value of $3,467.93. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 billion through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems. The Depakote DR delivery order represents a routine pharmaceutical supply requirement within the broader scope of the DLA Troop Support Medical prime vendor contract, which enables flexible fulfillment of federal medical supply needs across military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/21/25 |